Can Metformin Cause Yeast Infections?

Metformin does not cause yeast infections, and the available evidence points in the opposite direction: the drug appears to have mild antifungal properties and is associated with fewer fungal infection reports than other diabetes medications. The confusion is understandable, though, because the condition metformin treats, type 2 diabetes, is itself a well-established risk factor for yeast infections. When someone starts metformin and later develops a yeast infection, the culprit is almost always elevated blood sugar rather than the pill they are taking to bring it down.

The Real Culprit Is High Blood Sugar, Not Metformin

People with diabetes, especially those whose blood sugar is not well controlled, are significantly more prone to genital yeast infections. In women, this shows up as vulvovaginal candidiasis; in men, it appears as Candida balanitis, which occurs almost exclusively in uncircumcised men. High blood glucose promotes yeast attachment and growth directly, and it also interferes with the immune responses that would normally keep Candida in check.¹ This means that someone newly diagnosed with diabetes who starts metformin may already have conditions in their body that favor yeast overgrowth before the first dose of medication ever reaches their system.

Hyperglycemia does not just raise the sugar level in your blood. It raises glucose concentrations in urine, vaginal secretions, and skin folds, all environments where Candida thrives. Yeast feeds on sugar. When there is more sugar available in those tissues, yeast colonies grow faster and become harder for the immune system to clear. This is why glycemic control, getting blood sugar into a healthy range and keeping it there, is considered a key component of both preventing and treating recurrent yeast infections in people with diabetes.²

So the timeline is misleading. A person starts metformin, develops a yeast infection a few weeks later, and assumes the drug is responsible. In reality, metformin has not yet fully corrected the high blood sugar that is feeding the yeast. As glucose control improves over weeks and months, the frequency of yeast infections typically drops, not rises.

What Adverse Event Reports Actually Show

The strongest evidence that metformin is not a yeast-infection trigger comes from large-scale safety databases. A study analyzing the FDA’s Adverse Event Reporting System (FAERS) from 2013 to 2023 found that a total of 91 fungal infection cases were reported in association with metformin over that entire decade. To put that in perspective, metformin is one of the most widely prescribed drugs in the world, taken by tens of millions of people. The ratio of fungal infections to total adverse events for metformin was just 0.001, far lower than the rates seen with other diabetes medications.³

That same study also found something interesting: when metformin was added to SGLT2 inhibitors (a newer class of diabetes drug known for causing yeast infections), the combination actually resulted in fewer fungal infections than the SGLT2 inhibitor alone. This reduction was statistically significant across all three major SGLT2 inhibitors studied. Rather than contributing to the problem, metformin seemed to be offsetting some of the fungal risk introduced by the other drug.³

Adverse event databases have limitations. People report side effects voluntarily, so underreporting is common, and the reports do not prove that a drug caused the event. Still, when a drug genuinely increases yeast infection risk, these databases pick up the signal clearly, as they have done with SGLT2 inhibitors. The near-absence of a signal for metformin is telling.

Metformin Actually Has Antifungal Properties

This might seem counterintuitive for a diabetes drug, but lab research has shown that metformin can directly inhibit the growth of Candida albicans, the yeast species responsible for most genital yeast infections. In one study, metformin inhibited the growth of free-floating Candida cells, disrupted the yeast’s ability to form hyphae (the branching filaments that allow Candida to invade tissue), and altered cell structure in ways that weakened the organism. It also increased reactive oxygen species inside yeast cells and reduced their energy production, both of which make it harder for the yeast to survive.⁴

The same research found that metformin worked synergistically with existing antifungal drugs. When combined with amphotericin B, metformin boosted the drug’s effectiveness against free-floating Candida. When combined with caspofungin, it improved performance against Candida biofilms, the stubborn colonies that form on surfaces and are much harder to treat than individual yeast cells.⁴ Separate research has confirmed this pattern, noting that combinations of antifungal agents and metformin have better fungicidal action than antifungal drugs alone, with lower minimum concentrations needed to inhibit yeast growth.⁵

A caveat is important here: these are laboratory findings. The concentrations of metformin used to kill yeast in a petri dish are much higher than what circulates in your bloodstream when you take a standard oral dose. Nobody is proposing metformin as a replacement for antifungal creams or pills. But the lab data reinforces the point that metformin is not a drug that favors yeast growth. If anything, it is biochemically hostile to Candida.

How Metformin Changes Your Microbiome

Metformin is well known for altering the bacterial communities in the gut, and emerging research shows it also affects fungal communities. A study examining the gut mycobiome across multiple human populations found that metformin treatment was associated with shifts in the relative abundance of specific gut fungi, particularly in the genera Fusarium and Tetrapisipora. These changes were distinct from the fungal shifts caused by type 2 diabetes itself, confirming that metformin has its own independent effect on which fungi thrive in your gut.⁶

The researchers verified this by giving metformin to healthy mice that did not have diabetes, and the mice showed similar fungal shifts. That detail matters because it separates metformin’s effect from the effect of the disease. The shifts were described as subtle but statistically significant, and the long-term consequences of these changes are still being studied. Animal research has also shown that metformin can improve vaginal microbiota composition, increasing probiotic bacteria in rats fed a high-fructose diet that had disrupted their vaginal microbial balance.⁷

None of this means metformin is a probiotic or that it will prevent yeast infections on its own. But the microbiome data, taken together with the antifungal lab data and the adverse event numbers, paints a consistent picture: metformin is not making your yeast infection risk worse.

The Diabetes Drug That Does Cause Yeast Infections

If you are on diabetes medication and getting frequent yeast infections, the more likely pharmaceutical culprit is an SGLT2 inhibitor rather than metformin. SGLT2 inhibitors (sold under names like canagliflozin, dapagliflozin, and empagliflozin) work by making your kidneys dump excess glucose into your urine. That is effective for lowering blood sugar, but it creates a sugar-rich environment in the urinary tract and genital area, exactly the conditions Candida loves.

FAERS data from a review of adverse events showed that genital fungal infections made up a measurable portion of SGLT2 inhibitor reports. Canagliflozin alone accounted for 267 genital fungal infection reports, compared to just 3 for the canagliflozin-plus-metformin combination product and 2 for the dapagliflozin-plus-metformin combination.⁸ Genital yeast infections are now listed as a known side effect on SGLT2 inhibitor labels, and prescribers routinely discuss this risk with patients starting these drugs.

This distinction matters because many people with type 2 diabetes take both metformin and an SGLT2 inhibitor. If yeast infections appear after starting a combination regimen, the SGLT2 inhibitor is overwhelmingly the more likely trigger. Talking to your doctor about which specific medication was added or changed when infections began can help pinpoint the issue. Switching to a different SGLT2 inhibitor or adjusting the dose may help, though the class effect means all drugs in this category carry some elevated risk.

Practical Steps to Lower Yeast Infection Risk on Diabetes Medication

The single most effective thing you can do to reduce recurrent yeast infections while managing diabetes is to get your blood sugar under better control. That sounds obvious, but it is worth stating plainly because it is the intervention with the best evidence behind it. Every point of improvement in glucose management reduces the sugar available to Candida in your tissues.

Diet plays a role beyond just helping with blood sugar numbers. Although direct clinical trials of dietary changes for yeast infections are limited, restricting refined sugars has shown benefit in related conditions like recurrent vulvovaginal candidiasis. Animal research has even found that a ketogenic (very low-carbohydrate) diet can enhance the effectiveness of antifungal treatment against Candida infections. In mouse models, a ketogenic diet combined with the antifungal drug fluconazole significantly reduced fungal burden in organs compared to fluconazole alone, and also increased fluconazole concentrations in blood and tissue.² You do not need to go full keto, but cutting back on sugar and refined carbohydrates is a reasonable step if yeast infections are a recurring problem.

Beyond diet, basic hygiene practices can make a difference:

Keep genital areas dry: Candida thrives in warm, moist environments. Cotton underwear and changing out of damp clothing promptly can help.
Avoid irritating products: Scented soaps, douches, and sprays can disrupt the vaginal microbiome and create conditions favorable to yeast overgrowth.
Monitor blood sugar closely: If you notice a pattern of yeast infections coinciding with glucose spikes or periods of poor control, share that information with your healthcare provider.

These measures are especially important in the early months after a diabetes diagnosis, when blood sugar may not yet be well managed even with metformin on board.

Probiotics and Recurrent Yeast Infections

If you deal with yeast infections that keep coming back despite treating each episode, probiotics are worth knowing about. A systematic review and meta-analysis examining the role of probiotics in treating vulvovaginal candidiasis found that adding probiotics to standard antifungal therapy (azole drugs like fluconazole or clotrimazole) improved outcomes compared to antifungal treatment alone. The combination reduced positive yeast cultures after treatment, and the recurrence rate dropped sharply: roughly 7% in the probiotic group versus about 36% in the placebo group.⁹

That said, the evidence is still emerging. The review noted that probiotics alone, without antifungal medication, did not perform better than placebo for clearing active yeast infections. The benefit appears to be in combination: antifungal drugs handle the acute infection, and probiotics help prevent it from returning by supporting a healthier vaginal microbial environment. The specific strains studied were primarily Lactobacillus species, which are the dominant “friendly” bacteria in a healthy vagina.

For someone on metformin who is dealing with recurrent yeast infections, adding a probiotic alongside treatment for each episode is a reasonable conversation to have with your doctor. The recurrence-reduction data is encouraging, and the risk profile of oral or vaginal probiotics is low. Just don’t expect probiotics to replace antifungal treatment for an active infection.

When to Be Concerned About Recurring Infections

Occasional yeast infections are common and not necessarily a sign that something is wrong with your diabetes management or your medication. Most women will experience at least one in their lifetime regardless of their metabolic health. But if you are having four or more infections per year, that pattern deserves medical attention. Recurrent vulvovaginal candidiasis can signal that blood sugar is consistently too high, that there is an immune system issue, or that the Candida species involved is resistant to common antifungal treatments.

Some Candida species, particularly Candida glabrata, are naturally less responsive to fluconazole, the drug most commonly prescribed for yeast infections. If you keep getting infections that do not fully resolve with standard treatment, your doctor may order a culture to identify the specific species and test its drug sensitivity. This is more important than most people realize, because treating a resistant species with the wrong antifungal just selects for tougher organisms and makes the cycle harder to break.

Men with diabetes who develop recurrent balanitis (yeast infection of the foreskin and glans) face a similar situation. Circumcision status is a strong risk factor here, and persistent infections in uncircumcised men with diabetes sometimes lead to discussions about circumcision as a longer-term solution, though improved glucose control is always the first-line approach.¹

If you are taking metformin and experiencing yeast infections, the evidence strongly suggests the drug is not the problem. The underlying diabetes is. Staying consistent with your medication, working on glucose control, and addressing infections promptly when they occur is a far more productive approach than worrying about whether to stop or switch a drug that, if anything, may be helping your body fight yeast rather than encouraging it.